The biopharma world is here. Get the industry’s most comprehensive daily news reports at endpts.com/subscribe
Global
- Tweets 50,852
- Following 80
- Followers 32,500
- Likes 4,493
Vivodyne grows thousands of rice-sized bits of human tissue to test drugs before they reach patients. Why it made the Endpoints 11: endpoints.news/endpoints-11-…
1
1
915
Hear from CEO Andrei Georgescu and more honorees during exclusive interviews at our free virtual event Monday: events.endpoints.news/eleven…
1
528
Kali Therapeutics built its own pipeline on $18M instead of licensing from China, then sold its lead asset to Sanofi. Why it made the Endpoints 11: endpoints.news/endpoints-11-…
1
1
1,061
Watch interviews with CEO Weihao Xu and more honorees at our free virtual event Monday: events.endpoints.news/eleven…
445
Michelle Lee turned down an NYU faculty offer to build Medra, where 100+ AI robots run experiments around the clock. Why it made the Endpoints 11: endpoints.news/endpoints-11-…
1
2
906
Hear from Lee and more honorees in interviews at our free virtual event Monday. Register now: events.endpoints.news/eleven…
439
Medici Therapeutics vaccinates a patient's own immune cells against their tumor in the lab. Why it made the Endpoints 11: endpoints.news/endpoints-11-…
1
1
3
1,071
Watch interviews with CEO Denitsa Milanova and more honorees at our free virtual event Monday: events.endpoints.news/eleven…
1
1
557
Endpoints News retweeted
🏆Meet 2026's most exciting biotech startups!🏆
Last night @endpts presented the Endpoints 11 awards. It's an evening of ideas, science and risk, and we have a pretty good track record of choosing companies that have an impact.
endpoints.news/biotechs-best…
1
1
4
1,426
After 150 nominations, months of research and debate, 11 startups made the cut, with work spanning gene therapy, CAR-T, longevity, AI and robotics. Meet the 2026 Endpoints 11: endpoints.news/biotechs-best…
1
1
3
4,003
Join the winners, our editors and Harvard Wyss Institute's Don Ingber at the free virtual program: events.endpoints.news/eleven…
606
Novo's latest small deal gives Sweden's Nanexa up to $1.33B for delivery tech that could make its metabolic drugs monthly or quarterly shots. endpoints.news/novo-does-ano…
1
3
1,348
Heidi Overton, Trump's pick to run the FDA, faces the Senate on Thursday. We're live blogging the hearing. endpoints.news/live-fda-comm…
1
1,051
Endpoints News retweeted
@endpts will be live blogging Heidi Overton's confirmation hearing, set to begin any moment. Senate HELP members just took a five minute break to talk about some other votes, allow time for senators to show up.
endpoints.news/live-fda-comm…
1
1
6
1,312
Kyverna's CAR-T improved mobility by a median 49% at one year in patients with stiff person syndrome, data it plans to take to the FDA by the end of this year. endpoints.news/kyverna-says-…
2
1
8
1,630
Lilly signed another China deal, this one with Beijing's InnoCare for up to $3.35B across five drug targets. endpoints.news/in-another-ch…
1
1
6
1,836
Roche's kidney drug hit its Phase 3 goal, setting up a bid for accelerated approval in a crowded market. endpoints.news/roche-kidney-…
1
6
1,694
Basecamp Research raised $140M and revealed a six-program pipeline, the first test of whether its AI models can turn DNA data into drugs. endpoints.news/ai-startup-ba…
2
1,187
A pregnant mom. A fetal diagnosis. Medication from a secret network. 'There was no protocol' endpoints.news/in-a-changed-…
2
2
2,965
Roche's kidney drug passed a Phase 3 test, clearing a path to accelerated approval in a market Novartis already sells into. endpoints.news/roche-kidney-…
1
2
3
1,397